INSYS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Insys Therapeutics, Inc. to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insys Therapeutics, Inc. ("Insys" or the "Company") INSY.

On October 26, 2017, the U.S. Department of Justice announced that John N. Kapoor, the Company's co-founder and majority owner, "was arrested this morning in Arizona and charged with RICO conspiracy, as well as other felonies, including conspiracy to commit mail and wire fraud and conspiracy to violate the Anti-Kickback Law."

Specifically, the superseding indictment alleges that Kapoor and several other of Insys' former officers "conspired to bribe practitioners in various states […] in order to get them to prescribe a fentanyl-based pain medication." The medication in question, Subsys, "is a powerful narcotic intended to treat cancer patients suffering intense breakthrough pain."

Following this announcement, trading of Insys' shares has been halted.

If you invested in Insys stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/INSY. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171027005881/en/